Whalesbook
1. THE SEAMLESS LINK
The robust top-line performance in ITC's core cigarette segment, exceeding analyst expectations, is overshadowed by persistent margin pressures. While sales figures demonstrate continued consumer demand for its products, the 140 basis point year-on-year contraction in cigarette EBIT margin to 56.7% highlights a significant challenge in translating revenue growth into equivalent profit expansion. This compression, attributed to increased leaf tobacco prices, casts a shadow on the company's ability to absorb escalating operational costs.
2. THE CORE CATALYST
Motilal Oswal's research on ITC's 3QFY26 results reveals a complex picture. The brokerage noted that consolidated gross cigarette sales grew 8% year-on-year, surpassing its 7% estimate, and volumes increased by approximately 6.5% against a projected 6%. The premium cigarette segment reportedly continued its outperformance, contributing to the revenue gains. However, cigarette EBIT saw a more moderate increase of 5.7% year-on-year, falling short of the 6.4% estimate. This divergence points to profitability challenges despite volume and value growth. The EBIT margin contracted to 56.7%, a notable decrease from the estimated 57.7%, a situation exacerbated by rising leaf tobacco prices. This direct cost impact on the company's most profitable segment raises immediate questions about its ability to manage input cost volatility. The market's reaction has been muted, with the stock hovering around ₹303-309 on February 2, 2026, reflecting investor caution.
3. THE ANALYTICAL DEEP DIVE
Navigating the Tax Headwinds
Recent regulatory actions have significantly impacted ITC's stock. An excise duty hike on cigarettes, effective February 1, 2026, has led to a sharp decline in its market value, with investors losing an estimated ₹1 lakh crore in about a month and the stock falling approximately 15-20% year-to-date. This policy shift, introducing excise duties ranging from ₹2,050 to ₹8,500 per 1,000 sticks, alongside a 40% GST rate, has intensified concerns about demand destruction in India's price-sensitive market. Analysts believe this correction is policy-driven rather than a reflection of fundamental business deterioration. The company's current P/E ratio, reported between 11x and 19x on a TTM basis as of early February 2026, suggests a valuation that may not fully price in the near-term earnings impact from taxation. Its market capitalization stands around ₹3.87 lakh crore.
Competitive Landscape and Historical Context
ITC operates in a competitive environment with players like Godfrey Phillips India and VST Industries in the tobacco sector, and broader FMCG competitors including Hindustan Unilever and Nestlé. Historically, ITC's stock has reacted negatively to significant tax changes, with a recent period seeing substantial value erosion. The stock has experienced sharp drops, touching a 52-week low near ₹303 on February 2, 2026, and has seen a year-to-date decline of approximately 15%. The company has historically responded to tax increases with price hikes to protect margins, a strategy that could weigh on volumes in the current environment. The growth of the illicit tobacco market is also a significant concern, potentially impacting legal volumes and profitability. Despite these challenges, ITC maintains a dominant 80% market share in the organized domestic cigarette market.
Recent Business Developments
Beyond its core cigarette business, ITC has been active in expanding its FMCG portfolio. Recent news highlights initiatives such as the launch of gourmet coffee capsules by ITC Sunbean, new frozen food ranges, and efforts in climate-smart agriculture through ITCMAARS. These diversification efforts aim to mitigate risks associated with the tobacco segment and tap into other growth areas, though they may involve capital allocation towards lower-margin segments.
4. THE FUTURE OUTLOOK
Motilal Oswal has reiterated its Neutral rating on ITC, setting a Sum of the Parts (SoTP)-based target price of INR 365. This valuation implies a price-to-earnings multiple of 21 times the estimated earnings for December 2027. The brokerage acknowledges the company's resilient core performance but remains cautious due to the disrupted earnings outlook for the cigarette business following the excise duty hike. Systematix, another brokerage, has a 'Hold' call with a price target of Rs 355 and has lowered its FY26/FY27/FY28 revenue and EPS estimates, reflecting the impact of tax changes on realisations and margins. Concerns persist about the company's ability to fully offset the higher tax burden through price increases without negatively impacting volumes.